Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (1)
  • 2024 (1)
  • 2021 (2)
  • 2018 (2)

Subject

  • Drug Trafficking (3)
  • Congressional Affairs (2)
  • Diversion Division (1)
  • Guns/Weapons (1)
  • Money Laundering (1)
  • OCDETF/Task Force (1)
  • Outreach/Drug Prevention (1)
  • Public and Media Affairs - also see Congressional Affairs (1)

Drug Name

  • Fentanyl (42)
  • Cocaine (22)
  • Methamphetamine (19)
  • Heroin (10)
  • Marijuana (Cannabis) (7)
  • Opioids (5)
  • Oxycodone (5)
  • Marijuana Concentrates (2)
  • Ecstasy/MDMA (1)
  • GHB (1)
  • Ketamine (1)
  • Synthetic Opioids (5)
  • Psilocybin (1)

Field Division

  • Washington, DC (84)
  • Atlanta (15)
  • Detroit (7)
  • New York (7)
  • Miami (6)
  • New Orleans (4)
  • Dallas (3)
  • Rocky Mountain (3)
  • Chicago (2)
  • Houston (2)
  • New England (2)
  • Phoenix (2)
  • St. Louis (2)
  • El Paso (1)
  • Los Angeles (1)
  • Louisville (1)
  • New Jersey (1)
  • Omaha (1)
  • San Francisco (1)
  • Sede (6)
Clear All Results
PRESS RELEASE

DEA Launches Bold Bilateral Initiative to Dismantle Cartel Gatekeepers and Combat Synthetic Drug Trafficking

Agosto 18, 2025
WASHINGTON – The Drug Enforcement Administration announces a major new initiative to strengthen collaboration between the United States and Mexico in the fight against cartels, whose trafficking networks are responsible for flooding American communities with deadly synthetic drugs. At the core of this effort is Project Portero, DEA’s flagship operation...
Agosto 18, 2025
PRESS RELEASE

Federal Indictment Alleges Alliance Between Sinaloa Cartel and Money Launderers Linked to Chinese Underground Banking

Junio 18, 2024
Washington - The Justice Department today announced a 10-count superseding indictment charging Los Angeles-based associates of Mexico’s Sinaloa drug cartel with conspiring with money-laundering groups linked to Chinese underground banking to launder drug trafficking proceeds. During the conspiracy, more than $50 million in drug proceeds flowed between the Sinaloa Cartel...
Junio 18, 2024
PRESS RELEASE

Administrator Anne Milgram Remarks on the Overdose Epidemic

Noviembre 17, 2021
Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...
Noviembre 17, 2021
PRESS RELEASE

DEA 2020 Year in Review: Combatting Serious Drug-Related Threats During the Pandemic

Enero 14, 2021
WASHINGTON – With the unprecedented worldwide health emergency brought on by COVID-19, last year was filled with new challenges and increased risks. While much of the world focused on combating the pandemic, DEA continued to implement initiatives to combat violent drug traffickers who were intent on flooding cities and rural...
Enero 14, 2021
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

Agosto 31, 2018
WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
Agosto 31, 2018
PRESS RELEASE

Justice Department, DEA propose significant opioid manufacturing reduction in 2019

Agosto 16, 2018
WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...
Agosto 16, 2018
Showing 1 - 6 of 6 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster